Page 9 | Certara

Guide White Paper

A Practical Guide to Creating Effective Budget Impact Models

BaseCase empowers market access, medical, and sales teams to effectively engage decision-makers by translating complex…

CertaraJuly 1, 2025

Webinar

Pirana Tips and Tricks – Report Object Generation in Pirana

CertaraJuly 1, 2025

Blog

The Reference-scaled Average Bioequivalence (RSABE) Approach

We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…

CertaraJuly 1, 2025

Conference

SCDM 2025 Annual Conference

CertaraJuly 1, 2025

Press Coverage

The Medicine Maker: The Biosimulation Generation

The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…

Danielle PillsburyJuly 1, 2025

Blog

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…

CertaraJune 30, 2025

Blog

Maintain & Adapt Pharma Market Access Digital Tools Using Feedback

Maintain the credibility of your pharma market access digital tools through continuous updates based on…

CertaraJune 30, 2025

Blog

The Do’s and Don’ts of Define.xml

Discover the 6 dos and don’ts of creating compliant define.xml files for FDA submission with…

CertaraJune 27, 2025

Case Study

How Model-informed drug development rescue projects from a risky situation

Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…

CertaraJune 26, 2025

Press Coverage

Increasing Productivity In Pharma R&D Starts With Data

This article discusses the growing volume of raw data collected during clinical research, and how…

CertaraJune 25, 2025

A Practical Guide to Creating Effective Budget Impact Models

Pirana Tips and Tricks – Report Object Generation in Pirana

The Reference-scaled Average Bioequivalence (RSABE) Approach

SCDM 2025 Annual Conference

The Medicine Maker: The Biosimulation Generation

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Maintain & Adapt Pharma Market Access Digital Tools Using Feedback

The Do’s and Don’ts of Define.xml

How Model-informed drug development rescue projects from a risky situation

Increasing Productivity In Pharma R&D Starts With Data

Newsletter sign up

Quick links

Solutions

Contact